Internal Medicine, Nephrology · Montebello, CA
NPI
1497048672
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3114 W Beverly Blvd
Montebello, CA, 90640
Phone (323) 726-3868
Groups this clinician bills Medicare through
Medicare paid, 2024
$228K
1,751 services
Medicare patients, 2024
499
Average age 72
Drug cost, 2024
$968K
1,852 prescriptions
Company payments, 2025
$1,435
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lathika Raakesh was code 99233 (hospital e&m - subsequent), 888 times for 299 patients. In total Lathika Raakesh billed 1,751 services in 19 codes, and Medicare paid $228K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 888 | 299 | $103.39 | $92K |
| 99223 Hospital E&M - Initial | Facility | 220 | 202 | $147.44 | $32K |
| 90960 ESRD Related Services (not dialysis) | Office | 136 | 86 | $305.06 | $41K |
| 99291 Critical Care E&M | Facility | 92 | 40 | $184.70 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 80 | 35 | $13.70 | $1,096 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 55 | 14 | $57.29 | $3,151 |
| 99215 Office E&M - Established | Office | 54 | 22 | $126.52 | $6,832 |
| 90961 ESRD Related Services (not dialysis) | Office | 54 | 39 | $253.43 | $14K |
| 99214 Office E&M - Established | Office | 40 | 28 | $100.04 | $4,001 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 29 | 15 | $44.16 | $1,281 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 15 | $64.22 | $1,798 |
By year: 2022 $209K for 1,571 services; 2023 $133K for 932 services; 2024 $228K for 1,751 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lathika Raakesh prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 221 prescriptions and refills. In total Lathika Raakesh wrote 1,852 Medicare prescriptions that cost $968K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 221 | 247 | 40 | $134K |
| Kerendia Finerenone | 194 | 196 | 26 | $119K |
| Furosemide Generic | 133 | 214 | 42 | $564 |
| Losartan Potassium Generic | 122 | 251 | 34 | $733 |
| Velphoro Sucroferric Oxyhydroxide | 111 | 117 | 15 | $285K |
| Dapagliflozin Dapagliflozin Propanediol | 96 | 96 | 14 | $47K |
| Lokelma Sodium Zirconium Cyclosilicate | 93 | 131 | 19 | $70K |
| Epogen Epoetin Alfa | 83 | 83 | 13 | $46K |
| Mounjaro Tirzepatide | 63 | 65 | Under 11 | $63K |
| Amlodipine Besylate Generic | 54 | 112 | 14 | $234 |
| Lisinopril Generic | 40 | 104 | 11 | $328 |
| Ozempic Semaglutide | 37 | 45 | Under 11 | $34K |
| Allopurinol Generic | 35 | 46 | Under 11 | $149 |
| Calcitriol Generic | 32 | 76 | 12 | $903 |
| Atorvastatin Calcium Generic | 30 | 78 | 12 | $308 |
Brand drugs: 1,063 claims; generic drugs: 775 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lathika Raakesh $1,435 ($1,435 in general payments such as food, travel and fees) from 20 companies. The largest payer was Ardelyx, Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 8 | $197 |
| GlaxoSmithKline, LLC. GSK | 8 | $184 |
| Akebia Therapeutics Inc AKBA | 7 | $143 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $135 |
| Calliditas Therapeutics US Inc. | 4 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94.44 |
| Travere Therapeutics, Inc. TVTX | 4 | $82.08 |
| OPKO Pharmaceuticals, LLC | 4 | $76.59 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $71 |
| Amgen Inc. AMGN | 2 | $59.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.